» Articles » PMID: 39851057

Identification of Serum TRNA-derived Small RNAs Biosignature for Diagnosis of Tuberculosis

Overview
Date 2025 Jan 24
PMID 39851057
Authors
Affiliations
Soon will be listed here.
Abstract

The tRNA-derived small RNAs (tsRNAs) are a new class of non coding RNAs, which are stable in body fluids and can be used as potential biomarkers for disease diagnosis. However, the exact value of tsRNAs in the diagnosis of tuberculosis (TB) is still unclear. The objective of the present study was to evaluate the performance of the serum tsRNAs biosignature to distinguish between active TB, healthy controls, latent TB infection, and other respiratory diseases. The differential expression profiles of tsRNAs in serum from active TB patients and healthy controls were analyzed by high-throughput sequencing. A total of 905 subjects were prospectively recruited for our study from three different cohorts. Levels of tsRNA-Gly-CCC-2, tsRNA-Gly-GCC-1, and tsRNA-Lys-CTT-2-M2 were significantly elevated in the serum of TB patients compared to non-TB individuals, showing a correlation with lung injury severity and acid-fast bacilli grades in TB patients. The accuracy of the three-tsRNA biosignature for TB diagnosis was evaluated in the training ( = 289), test ( = 124), and prediction ( = 292) groups. By utilizing cross-validation with a random forest algorithm approach, the training cohort achieved a sensitivity of 100% and specificity of 100%. The test cohort exhibited a sensitivity of 75.8% and a specificity of 91.2%. Within the prediction group, the sensitivity and specificity were 73.1% and 92.5%, respectively. The three-tsRNA biosignature generally decreased within 3 months of treatment and then remained stable. In conclusion, the three-tsRNA biosignature might serve as biomarker to diagnose TB and to monitor the effectiveness of treatment in a high-burden TB clinical setting.

References
1.
Orellana E, Siegal E, Gregory R . tRNA dysregulation and disease. Nat Rev Genet. 2022; 23(11):651-664. PMC: 11170316. DOI: 10.1038/s41576-022-00501-9. View

2.
Wang S, Luo Z, Yuan L, Lin X, Tang Y, Yin L . tRNA-Derived Small RNAs: Novel Insights into the Pathogenesis and Treatment of Cardiovascular Diseases. J Cardiovasc Transl Res. 2022; 16(2):300-309. DOI: 10.1007/s12265-022-10322-0. View

3.
. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This.... Am J Respir Crit Care Med. 2000; 161(4 Pt 1):1376-95. DOI: 10.1164/ajrccm.161.4.16141. View

4.
Zhang X, Yang P, Khan A, Xu D, Chen S, Zhai J . Serum tsRNA as a novel molecular diagnostic biomarker for lupus nephritis. Clin Transl Med. 2022; 12(5):e830. PMC: 9121311. DOI: 10.1002/ctm2.830. View

5.
Roe J, Thomas N, Gil E, Best K, Tsaliki E, Morris-Jones S . Blood transcriptomic diagnosis of pulmonary and extrapulmonary tuberculosis. JCI Insight. 2016; 1(16):e87238. PMC: 5053151. DOI: 10.1172/jci.insight.87238. View